ASH Clinical News July 2017 V2

Drawing First Blood: Is MRD Testing Worthwhile in Myeloma? Your source for worldwide news and perspectives on hematology/oncology july 2017 volume 03 | number 08 CONTENTS Written in Blood Enoxaparin Increases ICH Risk in Glioma Literature Scan Blinatumomab Versus Standard of Care in ALL THE FDA WEIGHS IN Richard Pazdur, MD, director of the FDA’s Oncology Center of Excellence, on the new center’s innovative, integrative efforts to speed up the drug- approval process On Location Highlights from the 2017 ASCO Annual Meeting Patient Education Understanding Blood Clots DEPARTMENTS 6 UP FRONT 8 CLINICAL NEWS 31 TRAINING AND EDUCATION 36 FEATURES 44 BACK OF THE BOOK The Society Pages: Recent Promotions and Transitions Latest & Greatest: New and Noteworthy Research Data Stream: Health-Care Facts and Figures